Form 8.3 - Udg Healthcare Plc
August 16 2021 - 10:30AM
UK Regulatory
TIDMUDG
U.K. DISCLOSURE, Aug. 16, 2021 (GLOBE NEWSWIRE) --
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Glazer Capital,
LLC
-------------------------------------------------------- --------------------
Company dealt in UDG Healthcare plc
-------------------------------------------------------- --------------------
Class of relevant security to which the dealings being EUR0.05 ordinary
disclosed relate (Note 2) shares
-------------------------------------------------------- --------------------
Date of dealing August 13, 2021
-------------------------------------------------------- --------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short
----------------------------------- ---------------------- -------------
Number (%) Number (%)
----------------------------------- --------------- ----- -------- ---
(1) Relevant securities 0 (0%) 0 (0%)
----------------------------------- ---------------------- -------------
(2) Derivatives (other than
options) 13,304,375 (5.28%) 0 (0%)
----------------------------------- ---------------------- -------------
(3) Options and agreements to
purchase/sell 0 (0%) 0 (0%)
----------------------------------- ---------------------- -------------
Total 13,304,375 (5.28%) 0 (0%)
----------------------------------- ---------------------- -------------
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
---------------------------------------------- --------------- ---------------
Number (%) Number (%)
---------------------------------------------- -------- --- -------- ---
(1) Relevant securities
---------------------------------------------- --------------- ---------------
(2) Derivatives (other than options)
---------------------------------------------- --------------- ---------------
(3) Options and agreements to purchase/sell
---------------------------------------------- --------------- ---------------
Total
---------------------------------------------- --------------- ---------------
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
---------------- -------------------------------- --------------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
--------------- ----------------------- ------------------------------- ----------------
CFD Decreased Long 1,508,838 10.79 GBP
--------------- ----------------------- ------------------------------- ----------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of securities to which the option relates (Note Exercise Type, Expiry Option money
e.g. call option selling, 7) price e.g. date paid/received
purchasing, American, per unit
varying European (Note 5)
etc. etc.
------------------- ------------- -------------------------------------------------------- ---------- ----------- -------- ---------------
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note
e.g. call option 5)
------------------- ---------------------- ---------------------------------
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
----------------------- --------- ---------------------------
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-------------------------------------------------------------
None
-------------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure August 16, 2021
--------------------------------------------------------- -----------------
Contact name Megan Boylan
--------------------------------------------------------- -----------------
Telephone number (212) 808-7302
--------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which
connected
--------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note
10)
--------------------------------------------------------- -----------------
(END) Dow Jones Newswires
August 16, 2021 10:30 ET (14:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2024 to Jun 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Jun 2023 to Jun 2024
